AI Article Synopsis
- New β-lactam/β-lactamase inhibitors, such as ceftazidime/avibactam, meropenem/vaborbactam, and imipenem/relebactam, are showing promise in treating KPC-producing infections, but their effectiveness varies based on the specific genetic make-up of the bacteria.
- The study analyzed 104 KPC- isolates to understand how differences in their genetic profiles affected antibiotic efficacy, and found that mutations significantly influenced resistance levels.
- Time-kill tests revealed that ceftazidime/avibactam was effective across different isolates, while imipenem/relebactam struggled with certain mutations, indicating the need for targeted treatment strategies based on genetic
Article Abstract
Objectives: The availability of new β-lactam/β-lactamase inhibitors ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam have redefined contemporary treatment of carbapenemase-producing (KPC-) infections. We aimed to characterize and contrast the activity of these agents against genetically diverse KPC- clinical isolates.
Methods: We analysed genomes of 104 non-consecutive KPC- isolates and compared the antibiotic activity by KPC subtype and genotype. MICs were determined in triplicate by CLSI methods. Twenty representative isolates were selected for time-kill analyses against physiological steady-state and trough concentrations, as well as 4× MIC for each agent.
Results: Fifty-eight percent and 42% of isolates harboured KPC-2 and KPC-3, respectively. mutations were more common among KPC-2- compared with KPC-3-producing (< 0.0001); mutations were classified as IS insertion, glycine-aspartic acid insertion at position 134 (GD duplication) and other mutations. Compared to isolates with WT , ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam MICs were elevated for isolates with IS by 2-, 4- and 16-fold, respectively (< 0.05 for each). Against isolates with GD duplication, imipenem/relebactam and meropenem/vaborbactam MICs were increased, but ceftazidime/avibactam MICs were not. In time-kill studies, ceftazidime/avibactam-mediated killing correlated with ceftazidime/avibactam MICs, and did not vary across genotypes. Imipenem/relebactam was not bactericidal against any isolate at trough concentrations. At steady-state imipenem/relebactam concentrations, regrowth occurred more commonly for isolates with IS mutations. Log-kills were lower in the presence of meropenem/vaborbactam for isolates with GD duplication compared with IS mutations.
Conclusions: Our investigation identified key genotypes that attenuate, to varying degrees, the activity for each of the new β-lactam/β-lactamase inhibitors. Additional studies are needed to translate the importance of these observations into clinical practice.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035640 | PMC |
| http://dx.doi.org/10.1093/jacamr/dlad022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Deciphering antibiotic resistance genes and plasmids in pathogenic bacteria from 166 hospital effluents in Shanghai, China.
J Hazard Mater
November 2024
International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan, China; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China; Longhu Laboratory, Zhengzhou, Henan, China. Electronic address:
Although previous studies using phenotypic or metagenomic approaches have revealed the patterns of antibiotic resistance genes (ARGs) in hospital effluents in local regions, limited information is available regarding the antibiotic resistome and plasmidome in human pathogenic bacteria in hospital effluents of megacity in China. To address this knowledge gap, we analyzed effluent samples from 166 hospitals across 13 geographical districts in Shanghai, China, using both cultivation-based approaches and metagenomics. A total of 357 strains were isolated from these samples, with the predominant species being Escherichia coli (n = 61), Aeromonas hydrophila (n = 57), Klebsiella pneumoniae (n = 48), and Aeromonas caviae (n = 42).
View Article and Find Full Text PDFClinical evaluation of advanced MALDI-TOF MS for carbapenemase subtyping in Gram-negative isolates.
J Clin Microbiol
November 2024
R&D Center for Clinical Mass Spectrometry, Seegene Medical Foundation, Seoul, Republic of Korea.
Unlabelled: The spread of carbapenemase-producing Enterobacterales (CPE) is emerging as a significant clinical concern in tertiary hospitals and, in particular, long-term care facilities with deficiencies in infection control. This study aims to evaluate an advanced matrix-assisted laser desorption/ionization (A-MALDI) mass spectrometry method for the identification of carbapenemases and further discrimination of their subtypes in clinical isolates. The A-MALDI method was employed to detect CPE target proteins.
View Article and Find Full Text PDFB cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma.
J Immunother Cancer
November 2024
UofL Health Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky, USA
Background: The role of B cells in antitumor immunity remains controversial, with studies suggesting the protumor and antitumor activity. This controversy may be due to the heterogeneity in B cell populations, as the balance among the subtypes may impact tumor progression. The immunosuppressive regulatory B cells (Breg) release interleukin 10 (IL-10) but only represent a minor population.
View Article and Find Full Text PDFGenetic characteristics of clinical carbapenem-resistant Klebsiella pneumoniae: epidemic ST11 KPC-2-producing strains and non-negligible NDM-5-producing strains with diverse STs.
Sci Rep
October 2024
The School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, China.
Klebsiella pneumoniae is among the most important Gram-negative pathogens that can cause serious nosocomial infections. The emergence and prevalence of hypervirulent carbapenem-resistant K. pneumoniae (Hv-CRKP) pose a significant challenge to public health.
View Article and Find Full Text PDFThe pleiotropic roles of nSMase2-generated ceramide include regulation of intracellular ceramide signaling and exosome biogenesis. We investigated the effects of eliminating nSMase2 on early and advanced PDA, including its influence on the microenvironment. Employing the KPC mouse model of pancreatic cancer, we demonstrate that pancreatic epithelial nSMase2 ablation reduces neoplasia and promotes a PDA subtype switch from aggressive basal-like to classical.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!